Results 141 to 150 of about 37,430 (216)

Lenalidomide and its impact on exanthematous reactions: a case report

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Lenalidomide is a drug used mainly in the treatment of Multiple Myeloma and Myelodysplastic Syndrome. Despite its therapeutic benefits, lenalidomide can cause several adverse effects, including exanthematous reactions that can appear unexpectedly and ...
Cristiana Vieira-Maia, José E. Ramos, Ana C. Morgado   +2 more
doaj  

Chelator Free Radiolabeling and Preclinical Evaluation of η⁶-Arene Sandwich Complexes of Lenalidomide With Rhenium and Technetium-99m. [PDF]

Chembiochem
Nadeem Q, Battistin F, Valdés DH, Genady AR, Mendez LRS, Sadeghi S, Blacque O, Alberto R.   +7 more
europepmc   +1 more source

Celiac Disease Emerging After ASCT in Multiple Myeloma: A Rare Diagnostic Intersection and Literature Review. [PDF]

Case Rep Hematol
Musleh M, Alswij MA, Alhusein Q.
europepmc   +1 more source

Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study. [PDF]

Blood Cancer J
Pasvolsky O, Costa BA, Aljawai YM, Patel KK, Bashir Q, Sui D, Srour SA, Tanner MR, Popat UR, Saini NY, Hosing C, Ramdial JL, Lee HC, Kaufman GP, Thomas SK, Weber DM, Becnel M, Tang G, Orlowski RZ, Champlin RE, Nieto Y, Shpall EJ, Qazilbash MH.   +22 more
europepmc   +1 more source

Isolated del(5q) with myeloproliferative driver mutations: A systematic review of published cases and clinical implications. [PDF]

Ther Adv Hematol
Abdulgayoom M, Al-Mashdali AF, Alshurafa A, Afana MS, Babiker AM, Bakheet M, Mohamed SF, Yassin MA.   +7 more
europepmc   +1 more source

Limited lenalidomide exposure and access to rescue plerixafor can eliminate haemopoietic progenitor cell collection failure in multiple myeloma patients treated with bortezomib, lenalidomide and dexamethasone. [PDF]

Intern Med J
Matsamakis N, Berry M, Buehler J, Zantomio D.   +3 more
europepmc   +1 more source

T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell Immunity. [PDF]

Cancer J
van de Donk NWCJ, Smits F, O'Neill C, Hoekman J, Kruyswijk S, Baglio SR, Zweegman S, Korst CLBM.   +7 more
europepmc   +1 more source

Real-World Treatment Patterns and Physician Perspectives in Relapsed/Refractory Multiple Myeloma: Results From a Nationwide Italian GIMEMA Survey. [PDF]

EJHaem
Fazio F, Piciocchi A, de Fabritiis P, Messina M, Soddu S, Sargentini V, Di Raimondo F, Patriarca F, Musto P, Offidani M, Zamagni E, Bringhen S, Gentile M, Mele G, Fazi P, Petrucci M, Cavo M.   +16 more
europepmc   +1 more source

Erythema multiforme-like drug eruption in a patient with mycosis fungoides on durvalumab and lenalidomide. [PDF]

JAAD Case Rep
Crisan LL, Quach J, Zain J, Rosen ST, Querfeld C.   +4 more
europepmc   +1 more source

Severe plaque psoriasis exacerbation during lenalidomide maintenance after autologous stem cell transplantation for multiple myeloma. [PDF]

JAAD Case Rep
Mousa AM, Mahmoud-Katheer M, El Hariri M, Khazal M, Khudadah K, AlShuraiaan GM.   +5 more
europepmc   +1 more source